We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current GH market cap is 3.76B. The company's latest EPS is USD -3.8805 and P/E is -7.84.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 143.03M | 155.05M | 168.49M | 177.24M | 191.48M |
| Operating Income | -113.54M | -197.51M | -99.56M | -100.74M | -117.33M |
| Net Income | -86.1M | -187.04M | -114.99M | -102.63M | -107.75M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 214.38M | 286.73M | 373.65M | 449.54M | 563.95M |
| Operating Income | -82.37M | -254.95M | -411M | -544.38M | -564.73M |
| Net Income | -75.65M | -253.78M | -405.67M | -654.59M | -479.45M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.8B | 1.79B | 1.7B | 1.61B | 1.54B |
| Total Liabilities | 1.57B | 1.63B | 1.64B | 1.61B | 1.6B |
| Total Equity | 228.3M | 158.68M | 68.29M | -1.61M | -60.1M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 962.54M | 2.27B | 2.2B | 1.61B | 1.79B |
| Total Liabilities | 114.54M | 916.19M | 1.56B | 1.55B | 1.63B |
| Total Equity | 798.39M | 1.3B | 645.01M | 60.18M | 158.68M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -246.25M | -324.98M | -30.28M | -124.29M | -175.35M |
| Investing | 176.8M | 840.25M | 28.07M | 22.99M | -271.84M |
| Financing | 386.81M | 477.38M | -1.07M | 4.82M | 1.94M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -47.13M | -103.93M | -209.02M | -309.46M | -324.98M |
| Investing | -317.57M | -617.09M | -63.16M | 149.82M | 840.25M |
| Financing | 367.3M | 1.41B | -66.82M | -189.09M | 477.38M |
| Market Cap | 3.76B |
| Price to Earnings Ratio | -7.84 |
| Price to Sales Ratio | 6.66 |
| Price to Cash Ratio | 3.32 |
| Price to Book Ratio | 23.69 |
| Dividend Yield | - |
| Shares Outstanding | 123.55M |
| Average Volume (1 week) | 1.49M |
| Average Volume (1 Month) | 1.43M |
| 52 Week Change | 5.92% |
| 52 Week High | 38.53 |
| 52 Week Low | 15.81 |
| Spread (Intraday) | 3.95 (12.64%) |
| Company Name | Guardant Health Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.guardanthealth.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
